David Nierengarten
Stock Analyst at Wedbush
(4.86)
# 369
Out of 4,600 analysts
554
Total ratings
52.4%
Success rate
21.3%
Average return
Main Sectors:
Stocks Rated by David Nierengarten
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IRON Disc Medicine | Maintained: Buy | $88 | $77.80 | +13.11% | 21 | Jul 31, 2026 | |
| DMRA Damora Therapeutics | Maintained: Buy | $35 → $40 | $30.02 | +33.24% | 4 | Jul 30, 2026 | |
| KURA Kura Oncology | Maintained: Buy | $19 → $36 | $9.47 | +280.15% | 2 | Jul 28, 2026 | |
| KNSA Kiniksa Pharmaceuticals International, | Reiterated: Buy | $72 → $99 | $75.99 | +30.28% | 23 | Jul 28, 2026 | |
| NVCR NovoCure | Maintained: Hold | $18 → $20 | $16.27 | +22.93% | 15 | Jul 24, 2026 | |
| NUVB Nuvation Bio | Maintained: Buy | $11 | $6.44 | +70.81% | 28 | Jul 21, 2026 | |
| COAG Hemab Therapeutics Holdings | Maintained: Buy | $42 → $55 | $46.54 | +18.18% | 3 | Jul 13, 2026 | |
| ABVX ABIVAX Société Anonyme | Maintained: Hold | $110 → $140 | $125.19 | +11.83% | 6 | Jul 6, 2026 | |
| ARGX argenx SE | Maintained: Buy | $1,000 | $844.50 | +18.41% | 57 | Jun 24, 2026 | |
| TCRX TScan Therapeutics | Maintained: Buy | $5 | $0.7365 | +578.89% | 6 | Jun 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $135 | $134.19 | +0.60% | 14 | Jun 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $65 | $28.35 | +129.28% | 18 | Jun 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $80 → $100 | $104.94 | -4.71% | 9 | Jun 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 | $19.96 | +50.30% | 2 | Jun 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $55 | $42.84 | +28.38% | 21 | Jun 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 | $3.00 | +266.67% | 13 | Jun 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $22 → $60 | $25.67 | +133.74% | 16 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $165 | $98.13 | +68.14% | 8 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $45 | $31.42 | +43.22% | 3 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 | $8.87 | +181.85% | 8 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 → $11 | $7.92 | +38.89% | 3 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $75 | $55.13 | +36.04% | 33 | Mar 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $32 | $44.71 | -28.42% | 2 | Mar 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $23 | $11.07 | +107.77% | 5 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $13.47 | +48.48% | 22 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | kr 69.00 | kr 33.40 | +106.59% | 1 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $75 → $35 | $25.81 | +35.61% | 13 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $26 | $19.92 | +30.52% | 14 | Sep 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $8 | $22.25 | n/a | 11 | Jun 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $31 → $30 | $26.10 | n/a | 2 | May 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $5 | $2.57 | n/a | 20 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $33 | $25.06 | n/a | 10 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $50 | $47.79 | n/a | 15 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $2 | $5.71 | n/a | 5 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $12 | $2.98 | n/a | 1 | Apr 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $9 → $4 | $1.96 | n/a | 23 | Jul 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $4 → $2 | $29.17 | n/a | 5 | Jul 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $48 → $16 | $110.40 | n/a | 8 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $19 → $17 | $10.11 | n/a | 6 | Jan 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $68 → $53 | $11.32 | n/a | 14 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $34 → $32 | $3.90 | n/a | 11 | Jun 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €309.07 → €303.83 | €726.70 | n/a | 2 | Mar 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $9 → $10 | $0.0004 | n/a | 3 | Aug 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $19 → $36 | $3.13 | n/a | 7 | Jun 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $95 | $618.14 | n/a | 1 | Aug 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $55 → $13 | $8.49 | n/a | 2 | Apr 23, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $20 | $1.18 | n/a | 1 | Nov 28, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 → $16 | $5.01 | n/a | 6 | Oct 12, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $10 → $13 | $4.31 | n/a | 6 | Oct 24, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1.5 → $1 | $0.0001 | n/a | 7 | Aug 10, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2 | $0.9443 | n/a | 7 | Aug 3, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4 → $3 | $39.05 | n/a | 3 | May 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $9 | $1.34 | n/a | 4 | Nov 17, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $98.75 | n/a | 3 | Mar 31, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $28.35 | n/a | 1 | Mar 22, 2013 |
Disc Medicine
Jul 31, 2026
Maintained: Buy
Price Target: $88
Current: $77.80
Upside: +13.11%
Damora Therapeutics
Jul 30, 2026
Maintained: Buy
Price Target: $35 → $40
Current: $30.02
Upside: +33.24%
Kura Oncology
Jul 28, 2026
Maintained: Buy
Price Target: $19 → $36
Current: $9.47
Upside: +280.15%
Kiniksa Pharmaceuticals International,
Jul 28, 2026
Reiterated: Buy
Price Target: $72 → $99
Current: $75.99
Upside: +30.28%
NovoCure
Jul 24, 2026
Maintained: Hold
Price Target: $18 → $20
Current: $16.27
Upside: +22.93%
Nuvation Bio
Jul 21, 2026
Maintained: Buy
Price Target: $11
Current: $6.44
Upside: +70.81%
Hemab Therapeutics Holdings
Jul 13, 2026
Maintained: Buy
Price Target: $42 → $55
Current: $46.54
Upside: +18.18%
ABIVAX Société Anonyme
Jul 6, 2026
Maintained: Hold
Price Target: $110 → $140
Current: $125.19
Upside: +11.83%
argenx SE
Jun 24, 2026
Maintained: Buy
Price Target: $1,000
Current: $844.50
Upside: +18.41%
TScan Therapeutics
Jun 23, 2026
Maintained: Buy
Price Target: $5
Current: $0.7365
Upside: +578.89%
Jun 23, 2026
Downgraded: Hold
Price Target: $135
Current: $134.19
Upside: +0.60%
Jun 22, 2026
Maintained: Buy
Price Target: $65
Current: $28.35
Upside: +129.28%
Jun 16, 2026
Maintained: Buy
Price Target: $80 → $100
Current: $104.94
Upside: -4.71%
Jun 16, 2026
Maintained: Buy
Price Target: $30
Current: $19.96
Upside: +50.30%
Jun 15, 2026
Maintained: Buy
Price Target: $55
Current: $42.84
Upside: +28.38%
Jun 4, 2026
Maintained: Buy
Price Target: $11
Current: $3.00
Upside: +266.67%
May 18, 2026
Upgraded: Buy
Price Target: $22 → $60
Current: $25.67
Upside: +133.74%
May 14, 2026
Maintained: Buy
Price Target: $165
Current: $98.13
Upside: +68.14%
May 14, 2026
Maintained: Buy
Price Target: $45
Current: $31.42
Upside: +43.22%
May 13, 2026
Maintained: Buy
Price Target: $25
Current: $8.87
Upside: +181.85%
May 8, 2026
Maintained: Buy
Price Target: $8 → $11
Current: $7.92
Upside: +38.89%
Mar 31, 2026
Reiterated: Buy
Price Target: $75
Current: $55.13
Upside: +36.04%
Mar 17, 2026
Maintained: Buy
Price Target: $32
Current: $44.71
Upside: -28.42%
Mar 11, 2026
Maintained: Buy
Price Target: $23
Current: $11.07
Upside: +107.77%
Feb 24, 2026
Maintained: Buy
Price Target: $20
Current: $13.47
Upside: +48.48%
Jan 7, 2026
Initiated Coverage: Buy
Price Target: kr 69.00
Current: kr 33.40
Upside: +106.59%
Oct 14, 2025
Maintained: Hold
Price Target: $75 → $35
Current: $25.81
Upside: +35.61%
Sep 2, 2025
Maintained: Buy
Price Target: $26
Current: $19.92
Upside: +30.52%
Jun 26, 2025
Maintained: Hold
Price Target: $8
Current: $22.25
Upside: n/a
May 23, 2025
Maintained: Buy
Price Target: $31 → $30
Current: $26.10
Upside: n/a
May 14, 2025
Maintained: Hold
Price Target: $5
Current: $2.57
Upside: n/a
Mar 20, 2025
Maintained: Buy
Price Target: $33
Current: $25.06
Upside: n/a
Mar 17, 2025
Initiated Coverage: Buy
Price Target: $50
Current: $47.79
Upside: n/a
Aug 9, 2024
Maintained: Hold
Price Target: $2
Current: $5.71
Upside: n/a
Apr 2, 2024
Initiated Coverage: Buy
Price Target: $12
Current: $2.98
Upside: n/a
Jul 26, 2023
Maintained: Hold
Price Target: $9 → $4
Current: $1.96
Upside: n/a
Jul 12, 2023
Downgraded: Hold
Price Target: $4 → $2
Current: $29.17
Upside: n/a
Jan 26, 2023
Downgraded: Hold
Price Target: $48 → $16
Current: $110.40
Upside: n/a
Jan 25, 2023
Maintained: Buy
Price Target: $19 → $17
Current: $10.11
Upside: n/a
Nov 3, 2022
Maintained: Hold
Price Target: $68 → $53
Current: $11.32
Upside: n/a
Jun 16, 2021
Maintained: Buy
Price Target: $34 → $32
Current: $3.90
Upside: n/a
Mar 4, 2021
Maintained: Buy
Price Target: €309.07 → €303.83
Current: €726.70
Upside: n/a
Aug 7, 2020
Maintained: Hold
Price Target: $9 → $10
Current: $0.0004
Upside: n/a
Jun 18, 2019
Maintained: Buy
Price Target: $19 → $36
Current: $3.13
Upside: n/a
Aug 16, 2018
Reiterated: Buy
Price Target: $95
Current: $618.14
Upside: n/a
Apr 23, 2018
Maintained: Hold
Price Target: $55 → $13
Current: $8.49
Upside: n/a
Nov 28, 2017
Initiated Coverage: Buy
Price Target: $20
Current: $1.18
Upside: n/a
Oct 12, 2017
Reiterated: Buy
Price Target: $24 → $16
Current: $5.01
Upside: n/a
Oct 24, 2016
Reiterated: Hold
Price Target: $10 → $13
Current: $4.31
Upside: n/a
Aug 10, 2016
Reiterated: Hold
Price Target: $1.5 → $1
Current: $0.0001
Upside: n/a
Aug 3, 2016
Reiterated: Hold
Price Target: $2
Current: $0.9443
Upside: n/a
May 9, 2016
Maintained: Hold
Price Target: $4 → $3
Current: $39.05
Upside: n/a
Nov 17, 2015
Reiterated: Buy
Price Target: $16 → $9
Current: $1.34
Upside: n/a
Mar 31, 2014
Maintained: Sell
Price Target: n/a
Current: $98.75
Upside: n/a
Mar 22, 2013
Reiterated: Hold
Price Target: n/a
Current: $28.35
Upside: n/a